{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:55:30Z","timestamp":1763704530129},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.diagmicrobio.2008.11.012","type":"journal-article","created":{"date-parts":[[2009,1,10]],"date-time":"2009-01-10T06:02:58Z","timestamp":1231567378000},"page":"302-308","source":"Crossref","is-referenced-by-count":14,"title":["Antibacterial activity of telithromycin and comparators against pathogens isolated from patients with community-acquired respiratory tract infections: the Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin study year 5 (2003\u20132004)"],"prefix":"10.1016","volume":"63","author":[{"given":"Francesco","family":"Blasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jac\/dkg123","article-title":"Drugs of the 21st century: telithromycin (HMR 3647)\u2014the first ketolide","volume":"51","author":"Ackermann","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1099\/0022-1317-51-11-903","article-title":"Respiratory infections","volume":"51","author":"Cant","year":"2002","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib3","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Document M07-A7","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib4","series-title":"Performance standards for antimicrobial susceptibility testing; 16th informational supplement. Document M100-S16","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1086\/505871","article-title":"Macrolide resistance in bacteremic pneumococcal disease: implications for patient management","volume":"43","author":"Daneman","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib6","author":"European Medicines Agency"},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3201\/eid1106.050222","article-title":"Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance","volume":"11","author":"Farrell","year":"2005","journal-title":"Emerg. Infect Dis."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1128\/JCM.01653-06","article-title":"Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US study","volume":"45","author":"Farrell","year":"2007","journal-title":"J. Clin. Microbiol."},{"issue":"suppl A","key":"10.1016\/j.diagmicrobio.2008.11.012_bib9","first-page":"3","article-title":"Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study","volume":"44","author":"Felmingham","year":"2002","journal-title":"J. Infect."},{"issue":"Suppl. S1","key":"10.1016\/j.diagmicrobio.2008.11.012_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkf807","article-title":"The need for antimicrobial surveillance","volume":"50","author":"Felmingham","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jac\/45.2.191","article-title":"The Alexander Project 1996\u20131997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections","volume":"45","author":"Felmingham","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jinf.2007.04.006","article-title":"Regional trends in \u03b2-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001\u20132004","volume":"55","author":"Felmingham","year":"2007","journal-title":"J. Infect."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/srin.2000.18059","article-title":"The epidemiology of respiratory tract infections","volume":"15","author":"File","year":"2000","journal-title":"Semin. Respir. Infect."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0149-2918(01)80047-3","article-title":"Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials","volume":"23","author":"Fogarty","year":"2001","journal-title":"Clin. Ther."},{"issue":"Suppl S1","key":"10.1016\/j.diagmicrobio.2008.11.012_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jac\/dkf810","article-title":"The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections","volume":"50","author":"Hoban","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl","key":"10.1016\/j.diagmicrobio.2008.11.012_bib16","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/00006454-200308001-00002","article-title":"Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children","volume":"22","author":"Jacobs","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.diagmicrobio.2005.12.008","article-title":"Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999\u20132003)","volume":"56","author":"Johnson","year":"2006","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2008.11.012_bib18","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/jac\/48.2.225","article-title":"High proportion of pharyngeal carriers of commensal streptococci resistant to erythromycin in Spanish adults","volume":"48","author":"P\u00e9rez-Trallero","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib20","first-page":"1685","article-title":"Acute bacterial rhinosinusitis in adults: Part I. Evaluation","volume":"70","author":"Scheid","year":"2004","journal-title":"Am. Fam. Physician"},{"issue":"5 Suppl 2","key":"10.1016\/j.diagmicrobio.2008.11.012_bib21","doi-asserted-by":"crossref","first-page":"380S","DOI":"10.1378\/chest.117.5_suppl_2.380S","article-title":"Infectious etiology of acute exacerbations of chronic bronchitis","volume":"117","author":"Sethi","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jinf.2004.01.002","article-title":"Streptococcus pneumoniae and Streptococcus pyogenes isolated from a paediatric population in Great Britain and Ireland: the in vitro activity of telithromycin versus comparators","volume":"48","author":"Shackcloth","year":"2004","journal-title":"J. Infect"},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib23","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/313452","article-title":"Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibacterial resistance surveillance study conducted in the United States in 1994\u20131995","volume":"29","author":"Shortridge","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-0711-6-7","article-title":"Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children","volume":"6","author":"Sunakawa","year":"2007","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib25","author":"U.S Food and Drug Administration (FDA): Centre for drug evaluation and research"},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1183\/09031936.05.00055705","article-title":"Guidelines for the management of adult lower respiratory tract infections","volume":"26","author":"Woodhead","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00003495-200161040-00003","article-title":"Review of macrolides and ketolides: focus on respiratory tract infections","volume":"61","author":"Zhanel","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2008.11.012_bib28","first-page":"59","article-title":"Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia","volume":"2","author":"Zhanel","year":"2006","journal-title":"Ther. Clin. Risk Manag."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889308004987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889308004987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T11:22:29Z","timestamp":1545477749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889308004987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0732889308004987"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2008.11.012","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}